Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions
- PMID: 25654377
- PMCID: PMC4602724
- DOI: 10.1097/MD.0000000000000435
Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions
Abstract
The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with preinvasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity using ASCUS+ or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities using ASCUS+ or LSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity using ASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity using ASCUS+ or LSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, or HSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Similar articles
-
Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.Ann Diagn Pathol. 2009 Apr;13(2):73-7. doi: 10.1016/j.anndiagpath.2008.12.001. Epub 2009 Feb 5. Ann Diagn Pathol. 2009. PMID: 19302953 Clinical Trial.
-
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?J Fam Pract. 1998 Feb;46(2):125-34. J Fam Pract. 1998. PMID: 9487318
-
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749. JAMA. 2002. PMID: 12365959
-
Findings to date from the ASCUS-LSIL Triage Study (ALTS).Arch Pathol Lab Med. 2003 Aug;127(8):946-9. doi: 10.5858/2003-127-946-FTDFTA. Arch Pathol Lab Med. 2003. PMID: 12873166 Review.
-
Cervical Cancer Screening: A Review.JAMA. 2023 Aug 8;330(6):547-558. doi: 10.1001/jama.2023.13174. JAMA. 2023. PMID: 37552298 Review.
Cited by
-
Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China.Oncotarget. 2017 Apr 25;8(17):28502-28509. doi: 10.18632/oncotarget.16093. Oncotarget. 2017. PMID: 28415708 Free PMC article.
References
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guideline in Oncology: Cervical Cancer. Version 2. 2013 Panel Members Pennsylvania: National Comprehensive Cancer Network; 2013.
-
- Qian Y, Qing MX, Zheng R, et al. Analysis of incidence and mortality of cervical cancer in China. 2009. China Cancer 2013; 22:612–616.
-
- Li N, Dai M. Human papillomavirus infection in China: a multi-centric cross-sectional study. Chin J Dis Control Prev 2008; 12:411–415.